Northwestern University-NMDTI — Chicago, Illinois

Northwestern University-NMDTI is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Northwestern University-NMDTI has participated in 1 clinical trials.

Therapeutic areas: Breast Neoplasms, Pancreatic Neoplasms.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwestern University-NMDTI?

Northwestern University-NMDTI has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwestern University-NMDTI conducted?

Northwestern University-NMDTI has 1 clinical trials on record. Their work covers Breast Neoplasms, Pancreatic Neoplasms.

Is Northwestern University-NMDTI accredited by Crixeo Health?

Northwestern University-NMDTI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwestern University-NMDTI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.